Skip to main content
Fig. 7 | Lipids in Health and Disease

Fig. 7

From: Effects of Bifidobacterium and rosuvastatin on metabolic-associated fatty liver disease via the gut–liver axis

Fig. 7

a Numbers of OTUs in each group. b Confidence ellipses for each group. c Species differences in the gut microbiota among all five groups compared by LEfSe. d Phylum-level and e genus-level distributions of the gut microbiota of the rats in each group. f RA of Gemmatimonadetes compared among groups by one-way ANOVA followed by the least significant difference (LSD) multiple comparison test. #P < 0.05 compared with Group N, **P < 0.01 compared with Group M, *P < 0.05 compared with Group M. g RA of Proteobacteria, compared among groups by the Kruskal‒Wallis H test. #P < 0.05 compared with Group N

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X